Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
16
NMPA:16
Drug Approvals
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20258042
- Approval Date
- Mar 25, 2025
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20258016
- Approval Date
- Feb 18, 2025
NMPA
Caspofungin Acetate for Injection
- Product Name
- 注射用醋酸卡泊芬净
- Approval Number
- 国药准字H20253305
- Approval Date
- Jan 24, 2025
NMPA
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20244852
- Approval Date
- Sep 10, 2024
NMPA
Amiodarone Hydrochloride Injection
- Product Name
- 盐酸胺碘酮注射液
- Approval Number
- 国药准字H20244578
- Approval Date
- Jul 30, 2024
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20243425
- Approval Date
- Apr 7, 2024
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20243426
- Approval Date
- Apr 7, 2024
NMPA
Carboprost Tromethamine Injection
- Product Name
- 卡前列素氨丁三醇注射液
- Approval Number
- 国药准字H20234616
- Approval Date
- Dec 5, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found